Rang	Name	Position
1	Dr. Stuart M. Essig Ph.D.	CEO, President & Chairman
2	Ms. Lea Daniels Knight	Executive VP & CFO
3	Mr. Robert T. Davis Jr.	Executive Vice President of Tissue Reconstruction and Distributed Technologies
4	Mr. Michael J. McBreen	Executive VP & Chief Commercial Officer
5	Mr. Harvinder Pal Singh	Executive VP & President of International Business
6	Mr. Jeffrey A. Mosebrook	Senior VP of Finance & Principal Accounting Officer
7	Mr. Teshtar Elavia	Corporate VP & Chief Technology Officer
8	Christopher Ward	Senior Director of Investor Relations
9	Mr. Michael D. Hutchinson	Executive VP, Chief Legal Officer & Secretary
10	Laurene Isip	Vice President of Global Corporate Communications & Public Relations

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	BlackRock Inc	13,27%	0,16 Mrd. USD
2	Rubric Capital Management LP	9,97%	0,12 Mrd. USD
3	Vanguard Portfolio Management, LLC	4,74%	0,06 Mrd. USD
4	Morgan Stanley - Brokerage Accounts	4,61%	0,06 Mrd. USD
5	Fuller & Thaler Asset Management Inc	4,54%	0,06 Mrd. USD
6	Amvescap Plc.	4,48%	0,05 Mrd. USD
7	Paradigm Capital Management, Inc.	4,42%	0,05 Mrd. USD
8	Vanguard Capital Management, LLC	3,72%	0,05 Mrd. USD
9	State Street Corp	3,71%	0,05 Mrd. USD
10	Dimensional Fund Advisors, Inc.	2,85%	0,03 Mrd. USD
11	Neuberger Berman Group LLC	2,72%	0,03 Mrd. USD
12	The Goldman Sachs Group Inc	2,41%	0,03 Mrd. USD
13	Geode Capital Management, LLC	2,13%	0,03 Mrd. USD
14	Charles Schwab Investment Management Inc	2,07%	0,03 Mrd. USD
15	Wellington Management Company LLP	1,88%	0,02 Mrd. USD
16	Millennium Management LLC	1,85%	0,02 Mrd. USD
17	Bank of America Corp	1,82%	0,02 Mrd. USD
18	Systematic Financial Management LP	1,36%	0,02 Mrd. USD
19	Invenomic Capital Management, LP	1,30%	0,02 Mrd. USD
20	Allianz Asset Management AG	1,29%	0,02 Mrd. USD